Instruction Pages The information set out below provides a checklist of information that needs to be included in the Primary Care model Clinical Trial Agreement (PC-mCTA) in preparation for execution by the Parties. It is the Sponsor’s responsibility...Clinical Trial Agreement • May 14th, 2025
Add, remove and / or update recitals as applicable to the Clinical Trial (as a preamble to the Agreement, such changes do not constitute modification to the template Agreement). Recital E should be completed where a corporate Affiliate of the Sponsor is formally empowered by the Sponsor to sign the Agreement on behalf of the Sponsor thereby binding the Sponsor as Party to the Agreement (and should be removed where this is not the case). Recital F should be retained if the Sponsor has appointed a Legal Representative within the UK or EEA, with the Legal Representative named, and otherwise deleted. Recital G should be retained if the Sponsor intends to deliver the Clinical Trial in a hub and spoke model, with this Agreement forming a head agreement for sub-agreements with Other Trial Sites and otherwise deleted (note that retention or deletion of this recital should align with retention or deletion of 4.21 in the model Agreement).
Instruction Pages The information set out below provides a checklist of information that needs to be included in the Primary Care model Clinical Trial Agreement (PC-mCTA) in preparation for execution by the Parties. It is the Sponsor’s responsibility...Clinical Trial Agreement • December 13th, 2023
Add, remove and / or update recitals as applicable to the Clinical Trial (as a preamble to the Agreement, such changes do not constitute modification to the template Agreement). Recital D should be completed where a corporate Affiliate of the Sponsor is formally empowered by the Sponsor to sign the Agreement on behalf of the Sponsor thereby binding the Sponsor as Party to the Agreement (and should be removed where this is not the case). Recital E should be retained if the Trial Site is in Northern Ireland and otherwise deleted.
Instruction Pages The information set out below provides a checklist of information that needs to be included in the Primary Care model Clinical Trial Agreement (PC-mCTA) in preparation for execution by the Parties. It is the Sponsor’s responsibility...Clinical Trial Agreement • March 23rd, 2023
Add, remove and / or update recitals as applicable to the Clinical Trial (as a preamble to the Agreement, such changes do not constitute modification to the template Agreement). Recital D should be completed where a corporate Affiliate of the Sponsor is formally empowered by the Sponsor to sign the Agreement on behalf of the Sponsor thereby binding the Sponsor as Party to the Agreement (and should be removed where this is not the case). Recital E should be retained if the Trial Site is in Northern Ireland and otherwise deleted.